-
Something wrong with this record ?
An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole
K. Rudolf, E. Rudolf
Language English Country Great Britain
Document type Journal Article
- MeSH
- Apoptosis drug effects MeSH
- Autophagy drug effects MeSH
- Cell Cycle drug effects MeSH
- Cytochromes c metabolism MeSH
- JNK Mitogen-Activated Protein Kinases metabolism MeSH
- Middle Aged MeSH
- Humans MeSH
- Mebendazole analogs & derivatives pharmacology MeSH
- Melanoma drug therapy metabolism MeSH
- Membrane Potential, Mitochondrial drug effects MeSH
- Mitosis MeSH
- Cell Line, Tumor MeSH
- Tumor Suppressor Protein p53 metabolism MeSH
- Myeloid Cell Leukemia Sequence 1 Protein metabolism MeSH
- Antineoplastic Agents pharmacology MeSH
- Proto-Oncogene Proteins c-bcl-2 metabolism MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
Mitotic catastrophe induced by mictotubule-targeting drugs such as benzimidazole carbamates has been demonstrated to be an efficient mechanism for suppression of tumor cells growth and proliferation, with variable resulting endpoints. The present study was designed to explore some of these endpoints; i.e. the apoptosis as well as autophagy and their related signaling in several stabilized cell lines as well as human explant melanoma cells treated with flubendazole (FLU). FLU-induced mitotic catastrophe resulted in mitochondrial and caspase-dependent apoptosis, which occurred at various rates in all treated cells during 96 h of treatment. The process was characterized by enhanced transcriptional activity of TP53 and NF-κB as well as upregulated Noxa expression. Also, inactivation of Bcl-2, BclXL and Mcl-1 proteins by JNK mediated phosphorylation was observed. Although increased autophagic activity took place in treated cells too, no discernible functional linkage with ongoing cell death process was evidenced. Together these results advance our evidence over the effectiveness of FLU cytotoxicity-related killing of melanoma cells while calling for more extensive testing of melanoma samples as a prerequisite of further preclinical evaluation of FLU antineoplastic potential.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020090
- 003
- CZ-PrNML
- 005
- 20210830101708.0
- 007
- ta
- 008
- 210728s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.tiv.2020.104930 $2 doi
- 035 __
- $a (PubMed)32652169
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Rudolf, K $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic
- 245 13
- $a An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole / $c K. Rudolf, E. Rudolf
- 520 9_
- $a Mitotic catastrophe induced by mictotubule-targeting drugs such as benzimidazole carbamates has been demonstrated to be an efficient mechanism for suppression of tumor cells growth and proliferation, with variable resulting endpoints. The present study was designed to explore some of these endpoints; i.e. the apoptosis as well as autophagy and their related signaling in several stabilized cell lines as well as human explant melanoma cells treated with flubendazole (FLU). FLU-induced mitotic catastrophe resulted in mitochondrial and caspase-dependent apoptosis, which occurred at various rates in all treated cells during 96 h of treatment. The process was characterized by enhanced transcriptional activity of TP53 and NF-κB as well as upregulated Noxa expression. Also, inactivation of Bcl-2, BclXL and Mcl-1 proteins by JNK mediated phosphorylation was observed. Although increased autophagic activity took place in treated cells too, no discernible functional linkage with ongoing cell death process was evidenced. Together these results advance our evidence over the effectiveness of FLU cytotoxicity-related killing of melanoma cells while calling for more extensive testing of melanoma samples as a prerequisite of further preclinical evaluation of FLU antineoplastic potential.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a protinádorové látky $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a autofagie $x účinky léků $7 D001343
- 650 _2
- $a buněčný cyklus $x účinky léků $7 D002453
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a cytochromy c $x metabolismus $7 D045304
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a JNK mitogenem aktivované proteinkinasy $x metabolismus $7 D048031
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mebendazol $x analogy a deriváty $x farmakologie $7 D008463
- 650 _2
- $a melanom $x farmakoterapie $x metabolismus $7 D008545
- 650 _2
- $a membránový potenciál mitochondrií $x účinky léků $7 D053078
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mitóza $7 D008938
- 650 _2
- $a protein MCL-1 $x metabolismus $7 D064549
- 650 _2
- $a protoonkogenní proteiny c-bcl-2 $x metabolismus $7 D019253
- 650 _2
- $a nádorový supresorový protein p53 $x metabolismus $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rudolf, E $u Department of Medical Biology and Genetics, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic. Electronic address: rudolf@lfhk.cuni.cz
- 773 0_
- $w MED00004536 $t Toxicology in vitro : an international journal published in association with BIBRA $x 1879-3177 $g Roč. 68, č. - (2020), s. 104930
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32652169 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101708 $b ABA008
- 999 __
- $a ok $b bmc $g 1690807 $s 1140536
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 68 $c - $d 104930 $e 20200708 $i 1879-3177 $m Toxicology in vitro $n Toxicol In Vitro $x MED00004536
- LZP __
- $a Pubmed-20210728